Question 1

What is the catalog number for DiscoveryProbe™ NF-κB Signaling Compound Library Plus?

Accepted Answer

The catalog number for DiscoveryProbe™ NF-κB Signaling Compound Library Plus is L1044P-.1.

Question 2

What sizes are available for DiscoveryProbe™ NF-κB Signaling Compound Library Plus?

Accepted Answer

DiscoveryProbe™ NF-κB Signaling Compound Library Plus is available in the following size(s): 100 µL/Well (10 mM Solution) - 96 Well Racks With Screw Cap.

Question 3

Is DiscoveryProbe™ NF-κB Signaling Compound Library Plus in stock?

Accepted Answer

DiscoveryProbe™ NF-κB Signaling Compound Library Plus is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

What is DiscoveryProbe™ NF-κB Signaling Compound Library Plus used for?

Accepted Answer

A unique collection of 178 NF-κB inhibitors for NF-κB signaling pathway research.

Question 5

What temperature does this product ship at?

Accepted Answer

Shipping temperature is chosen based on the product’s stability needs, ranging from ambient to dry ice, and is indicated on the product page. Any related shipping fee is shown clearly in your quotation.

Question 6

What is the molecular weight of the target protein?

Accepted Answer

Molecular weight information, where applicable, is listed on the datasheet under target details, useful for confirming the correct band on western blot.

Question 7

How long will it take to receive this product if it’s custom made?

Accepted Answer

Lead times depend on the product type: custom polyclonal antibodies typically take 12-14 weeks, monoclonal antibodies 15-17 weeks, made-to-order recombinant proteins 4-8 weeks, and made-to-order recombinant antibodies 6-8 weeks. These are estimates and may shift due to production delays.

DiscoveryProbe™ NF-κB Signaling Compound Library Plus

Product Specifications

Field of Research

Shipping Conditions

Storage Conditions

Frequently Asked Questions

Explore Other Products

Frozen Tissue Sections, Breast

PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746), CF488A conjugate, 0.1mg/mL

CD8A Polyclonal Antibody

CD8A Polyclonal Antibody

CD8A Polyclonal Antibody

Z/E-Guggulsterone